The impact of evidence-based education on prescribing in a psychiatry residency

Journal of Psychiatric Practice

Volumn 17, Issue 2, 2011, Pages 110-117

  Benjamin, Dinesh ^a,b   Swartz, Marvin ^a   Forman, Leslie ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

antipsychotics; generic medications; prescribing patterns; psychiatric residents; psychotropic medications; residency training

Indexed keywords

ANTIDEPRESSANT AGENT; GENERIC DRUG; MOOD STABILIZER; PSYCHOTROPIC AGENT;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; EVIDENCE BASED MEDICINE; HUMAN; PERSONAL EXPERIENCE; PRESCRIPTION; PSYCHIATRY; RESIDENCY EDUCATION;

ADULT; ANTIPSYCHOTIC AGENTS; DRUG PRESCRIPTIONS; DRUGS, GENERIC; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; INTERNSHIP AND RESIDENCY; MALE; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTION DRUGS; PSYCHIATRY;

EID: 79954484073     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000396062.12893.5b     Document Type: Article

References (19)

1. Duggan M. Do new prescription drugs pay for themselves ?The case of second-generation antipsychotics. J Health Econ 2005;24:1-31. (Pubitemid 40023070)
2. Rosenheck RA, Leslie DL, Doshi JA. Second-generation antipsychotics: Cost-effectiveness, policy options, and political decision making. Psychiatr Serv 2008;59:515-20.
3. Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005;353:1209-23. (Pubitemid 41345943)
4. Rosenheck RA, Leslie DL, Sindelar J, et al. Cost-effectiveness of second-generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. Am J Psychiatry 2006;163:2080-9. (Pubitemid 46114227)
5. Rosenheck R, Perlick D, Bingham S, et al. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: A randomized controlled trial. JAMA 2003;290:2693-702. (Pubitemid 37475597)
6. Jones PB, Barnes TR, Davies L, et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006;63:1079-87. (Pubitemid 44498387)
7. Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-analysis. Lancet 2009;373:31-41.
8. Covell NH, Finnerty MT, Essock SM. Implications of CATIE for mental health services researchers. Psychiatr Serv 2008;59:526-9.
9. Forsner T, Hansson J, Brommels M, et al. Implementing clinical guidelines in psychiatry: A qualitative study of perceived facilitators and barriers. BMC Psychiatry 2010;10:8.
10. Shrank WH, Choudhry NK, Solomon DH, et al. Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial. Am Heart J 2009;157:613-9.
11. Michie S, Fixsen D, Grimshaw JM, et al. Specifying and reporting complex behaviour change interventions: The need for a scientific method. Implement Sci 2009;4:40.
12. Kirkpatrick D, ed. Evaluating training programs: The four levels. second edition. San Francisco, CA: Berrett-Koehler Publishers; 1998.
13. Steinman MA, Schillinger D. Drug detailing in academic medical centers: Regulating for the right reasons, with the right evidence, at the right time. Am J Bioeth 2010;10: 21-3.
14. Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med 1982;73:4-8. (Pubitemid 12048270)
15. Davis DA, Thomson MA, Oxman AD, et al. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995;274: 700-5.
16. Soumerai SB. Principles and uses of academic detailing to improve the management of psychiatric disorders. Int J Psychiatry Med 1998;28:81-96. (Pubitemid 28275048)
17. Rosenheck RA, Sernyak MJ. Developing a policy for second- generation antipsychotic drugs. Health Aff (Millwood) 2009;28:w782-93.
18. Stowell KR, Ghinassi FA, Fabian TJ, et al. Best practices: An intervention to promote evidence-based prescribing at a large psychiatric hospital. Psychiatr Serv 2009;60: 294-6.
19. Jefferson JW. Old versus new medications: How much should be taught? Acad Psychiatry 2005;29:162-6.